Oral Anabolic Steroids Cabergoline for Bodybuilding

Oral Anabolic Steroids Cabergoline for Bodybuilding Product Name: Cabergoline Synonyms: 6-allyl-n-[3-(dimethylamino)propyl]-n-(ethylcarbamoyl)ergoline-8-carboxamide;CABERGOLINE;(8-beta)-(2-propenyl);n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-ergoline-8-carboxamid;FCE-21336,Cabaser,Dostinex;(8b)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)- ergoline-8-carboxamide;Cabaser;Dostine CAS: 81409-90-7 MF: C26H37N5O2 MW: 451.6 Chemical Properties White Crystalline Solid Usage A dopamine D2-receptor agonist. Usage receptor stimulant Cabergoline uses 1. hyperprolactinemia 2. adjunctive therapy of prolactin-producing pituitary gland tumors (prolactinomas); 3. monotherapy of Parkinson's disease in the early phase; 4. combination therapy, together with levodopa and a decarboxylase inhibitor such as carbidopa, in progressive-phase Parkinson's disease; 5. in some countries also: ablactation and dysfunctions associated with hyperprolactinemia (amenorrhea, oligomenorrhea, anovulation, nonpuerperal mastitis and galactorrhea); 6. treatment of uterine fibroids. 7. adjunctive therapy of acromegaly, cabergoline has low efficacy in suppressing levels and is highly efficient in suppressing hyperprolactinemia that is present in 20-30% of acromegaly cases; 8.and prolactin are similar structurally and have similar effects in many target tissues, therefore targeting prolactin may help symptoms when hormone secretion can not be sufficiently controlled by other methods; 9. Cushing's disease - cabergoline may be used to lower ACTH levels and cause regression of ACTH producing pituitary adenomas; 10. other pituitary adenomas - cabergoline has demonstrated certain efficacy in controlling or reducing other kinds of pituitary adenomas, as well as silent or non-functional adenomas. Cabergoline Dosage: Parkinson's disease: Monotherapy: Initial dose should be 0.5 mg daily. The usual maintenance dose is 2 to 4 mg daily. Combination therapy: Usually 2 to 6 mg daily. Tumors of the pituitary gland and other hyperprolactinemic conditions: Initially 0.5 mg per week, slowly titrated to 4.5 mg per week, if necessary. Ablactation: According to specific treatment scheme. Welcome to contact: Skype: rdy705 nutrition@chembj.com WhatsApp: +8618578209860 url:http://www.nutritionraws.com